Quick Takeaways
- Panacea Innovation Ltd filed SCHEDULE 13D/A for Connect Biopharma Holdings Limited Ordinary Shares (CNTB).
- Disclosed ownership: 25%.
- Date of event: 21 Jul 2025.
Quoteable Key Fact
"Panacea Innovation Ltd disclosed 25% ownership in Connect Biopharma Holdings Limited Ordinary Shares (CNTB) on 21 Jul 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Panacea Innovation Limited | 25% | 13,950,000 | 0 | 13,950,000 | /s/ James Huang | James Huang, Founding Managing Partner | 0002010692 |
| Panacea Venture Healthcare Fund II, L.P. | 25% | 13,950,000 | 0 | 13,950,000 | By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang | James Huang, Founding Managing Partner | 0001869939 |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 25% | 13,950,000 | 0 | 13,950,000 | By: Panacea Innovation Limited, its sole owner, /s/ James Huang | James Huang, Founding Managing Partner | |
| James Huang | 25% | 13,950,000 | 0 | 13,950,000 | /s/ James Huang | James Huang | 0001573160 |